Gene therapy to fight blood cancer succeeds in study – The Recorder (subscription)
The Recorder (subscription) |
Gene therapy to fight blood cancer succeeds in study
The Recorder (subscription) In this May 2016 photo provided by Kite Pharma, cell therapy specialists at the company’s manufacturing facility in El Segundo, Calif., prepare blood cells from a patient to be engineered in the lab to fight cancer. The experimental gene therapy … |
Genetic Engineering & Biotechnology News |
An Efficient Single-Nucleotide Editing CRISPR
Genetic Engineering & Biotechnology News Since the discovery of the genome-editing tool CRISPR/Cas9, scientists have been looking to utilize the technology to make a significant impact on correcting genetic diseases. Technical challenges have made it difficult to use this method to correct … Who should own revolutionary gene editor CRISPR? Scientists or the public?Genetic Literacy Project UW scientists research role of gene-editing in curing inherited diseasesThe Badger Herald Important decision from the USPTO in the field of genome engineeringLexology (registration) Benchmark Monitor all 4 news articles » |
Fox News |
Gene therapy to fight a blood cancer succeeds in major study
Fox News An experimental gene therapy that turns a patient’s own blood cells into cancer killers worked in a major study, with more than one-third of very sick lymphoma patients showing no sign of disease six months after a single treatment, its maker said Tuesday. |
|
The stem cell dynamics of wound healing
Medical Xpress “It was particularly exciting to observe that the repair of the skin epidermis involves the activation of very different stem cells that react the same way to the emergency situation of the wound and have the power to completely restore the damaged … |
|
International Stem Cell Corporation Announces Third Patient with Parkinson’s Disease in Phase I Clinical Trial
GlobeNewswire (press release) CARLSBAD, Calif., Feb. 28, 2017 (GLOBE NEWSWIRE) — International Stem Cell Corporation (OTCQB:ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies and biomedical products, today announced the … |